From: Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England
Outcome
Severe renal disease
(n = 1422)
Active cancer
(n = 910)
COVID-19-attributable hospitalization, n (%)
18 (1.3)
10 (1.1)
Any-cause hospitalization, n (%)
97 (6.8)
89 (9.8)
All-cause deaths, n (%)
4 (0.3)
7 (0.8)